Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Journal article
Pouwels KB. et al, (2021), Nature Medicine, 27, 2127 - 2135
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Journal article
Ogbe A. et al, (2021), Nature Communications, 12
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Journal article
Payne RP. et al, (2021), Cell, 184, 5699 - 5714.e11
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Journal article
Wei J. et al, (2021), Nature Communications, 12
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status
Journal article
Eyre DW. et al, (2021), Clinical Microbiology and Infection, 27, 1516.e7 - 1516.e14
Viral detection and identification in 20 min by rapid single-particle fluorescence in-situ hybridization of viral RNA.
Journal article
Hepp C. et al, (2021), Scientific reports, 11
Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019.
Journal article
Wang T. et al, (2021), Hepatol Commun, 5, 1586 - 1604
Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
Journal article
Campbell C. et al, (2021), Frontiers in Medicine, 8
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers
Journal article
Lumley SF. et al, (2021), Clinical Infectious Diseases, 73, e699 - e709
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time
Journal article
Walker AS. et al, (2021), eLife, 10
Cuts to UK official development assistance budget jeopardise global viral hepatitis elimination goals.
Journal article
Lemoine M. et al, (2021), The lancet. Gastroenterology & hepatology, 6, 527 - 528
Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study.
Journal article
Wang T. et al, (2021), BMC infectious diseases, 21
Equity for excellence in academic institutions: a manifesto for change
Journal article
Wedekind L. et al, (2021), Wellcome Open Research, 6, 142 - 142
Diagnosis of SARS-CoV-2 Infection with LamPORE, a High-Throughput Platform Combining Loop-Mediated Isothermal Amplification and Nanopore Sequencing
Journal article
Peto L. et al, (2021), Journal of Clinical Microbiology, 59
COVID-19 CT pulmonary angiogram examinations and reported pulmonary embolism incidence: comparison between peak first wave and early second wave.
Journal article
Tsakok MT. et al, (2021), Clinical radiology, 76, 310 - 312
Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection
Journal article
Downs LO. et al, (2021), Wellcome Open Research, 5, 240 - 240
Equity for excellence in academic institutions: a manifesto for change.
Journal article
Wedekind L. et al, (2021), Wellcome open research, 6
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis
Journal article
Campbell C. et al, (2020), Journal of Viral Hepatitis
Efficacy and safety of tenofovir disoproxil fumarate (TDF) in hepatitis B virus (HBV) monoinfection: longitudinal analysis of a UK cohort
Journal article
Wang T. et al, (2020)
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Journal article
Ainsworth M. et al, (2020), The Lancet Infectious Diseases, 20, 1390 - 1400